Search

everythinglearnresearchcommunity

for

Search:↓

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Cerament effectively corrected forehead irregularities in one patient, and various surgical techniques successfully reconstructed perioral soft tissue in 14 patients.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ruxolitinib treatment may cause eyelash growth.

Most pregnant women experience skin changes, mainly increased pigmentation, and some develop pregnancy-related skin conditions and infections.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Viral warts are common in children, so prevention against HPV is important.

Submental tissue is good for repairing mouth area skin with minimal scarring and good cosmetic results.

Oral zinc and topical steroids can effectively treat chronic scalp pustules and hair loss in elderly patients.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.